J&J, P&G sued after FDA panel ruling on decongestant - Business Insurance (2024)

"); //googletag.cmd.push(function () { googletag.display('rectangle-1'); }); // $("#dvContent > p:eq(5)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-2'); }); $("#dvContent").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-3'); }); } else if (($("#dvContent > p").length / 3 >= 4 && $("#dvContent > p").length / 3 < 5)){ $("#dvContent > p:eq(3)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-1'); }); //$("#dvContent > p:eq(7)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-2'); }); $("#dvContent").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-3'); }); } else if (($("#dvContent > p").length / 3 >= 5 && $("#dvContent > p").length / 3 < 6)){ $("#dvContent > p:eq(4)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-1'); }); //$("#dvContent > p:eq(9)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-2'); }); $("#dvContent").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-3'); }); } else if (($("#dvContent > p").length / 3 < 3)){ $("#dvContent > p:eq(1)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-1'); }); //$("#dvContent > p:eq(3)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-2'); }); $("#dvContent").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-3'); }); } else{ $("#dvContent > p:eq(6)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-1'); }); //$("#dvContent > p:eq(12)").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-2'); }); $("#dvContent").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-3'); }); } } else{ $("#dvContent").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-1'); }); //$("#dvContent").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-2'); }); // $("#dvContent").after("

"); //googletag.cmd.push(function () { googletag.display('rectangle-3'); }); } } if ('False' == 'True'){ $('.rsrch_img').bind('contextmenu', function(e) { return false; }); } if('912359848' == '912355452' ||'912359848' == '912355091' ||'912359848' == '912355092' ||'912359848' == '912353880' ||'912359848' == '912353916' ||'912359848' == '912353917' ||'912359848' == '912352756' || '912359848' == '912352742' ||'912359848' == '912352755' ||'912359848' == '912352024' ||'912359848' == '912352025' || '912359848' == '912352026' || '912359848' == '912352027' || '912359848' == '912352028' || '912359848' == '912352036' || '912359848' == '912350960' || '912359848' == '912350992' ||'912359848' == '912350146' || '912359848' == '912350168' ||'912359848' == '912349535' ||'912359848' == '912349542' ||'912359848' == '912348731' ||'912359848' == '912348727' ||'912359848' == '912348170' ||'912359848' == '912348173' ||'912359848' == '912353333' ||'912359848' == '912353334' ||'912359848' == '912346128' ||'912359848' == '912346129' ||'912359848' == '912345488' ||'912359848' == '912345483' || '912359848' == '912345491' ||'912359848' == '912345489' ||'912359848' == '912344856' || '912359848' == '912344842' ||'912359848' == '912344107' || '912359848' == '912344380'|| '912359848' == '912344108' || '912359848' == '912344109' || '912359848' == '912344110' || '912359848' == '912344111' || '912359848' == '912344104' ||'912359848' == '912344056' || '912359848' == '912342960' ||'912359848' == '912342942' ||'912359848' == '912342075' || '912359848' == '912342077' || '912359848' == '912333651' || '912359848' == '912335411' || '912359848' == '912336256' || '912359848' == '912336286' || '912359848' == '912336287' || '912359848' == '912336288' || '912359848' == '912336289' || '912359848' == '912336290' || '912359848' == '912336689' || '912359848' == '912336905' || '912359848' == '912337387' || '912359848' == '912337984' || '912359848' == '912339338' || '912359848' == '912339689' || '912359848' == '912340071' || '912359848' == '912340072' || '912359848' == '912340953' || '912359848' == '912340601' || '912359848' == '912355819' || '912359848' == '912354530' || '912359848' == '912356329' || '912359848' == '912356335' || '912359848' == '912357052'|| '912359848' == '912357056' || '912359848' == '912357622' || '912359848' == '912357635' || '912359848' == '912357619' || '912359848' == '912358431' || '912359848' == '912358557' || '912359848' == '912359429' || '912359848' == '912359430' || '912359848' == '912359431' || '912359848' == '912359432' || '912359848' == '912359433' || '912359848' == '912359434' || '912359848' == '912360093' || '912359848' == '912360078' || '912359848' == '912360094' || '912359848' == '912360648'|| '912359848' == '912360639' || '912359848' == '912360649' || '912359848' == '912361180' || '912359848' == '912361181' || '912359848' == '912362444' || '912359848' == '912362443' || '912359848' == '912362856' || '912359848' == '912362857' || '912359848' == '912363336' || '912359848' == '912363337' || '912359848' == '912363359'|| '912359848' == '912364048'|| '912359848' == '912364052'|| '912359848' == '912364053'){ $('.homepagerightsection').hide(); $('.homepageleftsection').css({width:'100%'}); $('#dvContent img').css('width', '100%'); } $.get('/Home/GetReadersPollForArticlePage', { articleID: '912359848' }, function (response) { var options = ""; if (response != null && response.length > 0 && !response[0].IsAlreadyAnswered) { $('#PollQuestion').text(response[0].Question); $.each(response, function (index, obj) { options = options + "

  • " }); $('#hdnPollQuestionID').val(response[0].PollQuestionID); $('#PollOption').append(options); $('#dvReaderPoll').show(); } }); }); function fnShowMore() { $('#lnkLess').show(); $('#lnkMore').hide(); $('.sharelist .tags').show(); } function fnShowLess() { var firstLineTop = $('.sharelist .tags:first').offset().top; $('#lnkLess').hide(); $('#lnkMore').show(); $('.sharelist .tags').filter(function () { return $(this).offset().top > firstLineTop; }).hide(); $('.sharelist .tags:visible:last').hide(); } function fnEmailToFriend(articleId) { var articleUrl = window.location.href; var tempUrl = '/Article/EmailToFriend?articleID=articleId&articleURL=articleUrl'; var Url = tempUrl.replace("articleId", articleId).replace("articleUrl", articleUrl); Url = Url.replace("&", "&").replace("&", "&").replace("&", "&"); $.fancybox({ href: Url, 'padding': 30, 'height': 480, 'width': 700, 'autoSize': false, 'autoScale': true, 'closeBtn': true, 'showCloseButton': true, 'transitionIn': 'fade', 'transitionOut': 'fade', 'type': 'iframe', 'padding': 10, hideOnOverlayClick: false, helpers: { overlay: { closeClick: false } } }); } function fnUpdateArticleViewCount() { $.ajax({ url: '/Article/UpdateViewCount', datatype : 'json', data: { articleID: 912359848 }, success: function (data) { } }); } function fnShowNonUserArticleAccessMessage(){ $.ajax({ url: '/Article/ShowArticle', cache: false, async: false, success: function (response) { if (response != null && response != undefined && response.viewCount != null && response.viewCount != undefined) { if (response.isUserLoggedIn == false && (response.viewCount == 2)) { //fnShowArticlePopup('912359848'); } } } }); } function fnShowArticlePopup() { $.fancybox({ 'padding': 5, 'height': 300, 'width': 700, type: 'iframe', href: '/Article/GuestUserArticleAccessPopup?articleID=912359848', autoSize: false, closeBtn: true, transitionIn: 'fade', transitionOut: 'fade', centerOnScroll: true, overlayOpacity: 0.2, overlayColor: '#666', helpers: { overlay: { closeClick: false } } }); $('.fancybox-wrap').css({'top':'100px', 'bottom':'auto'}); } $(".fancybox").fancybox({ openEffect: 'elastic', closeEffect: 'elastic', prevEffect: 'fade', nextEffect: 'fade', fitToView: false, // images won't be scaled to fit to browser's height maxWidth: "90%", // images won't exceed the browser's width helpers: { overlay: { locked: false } }, beforeShow: function () { if ('False' == 'True'){ /* Disable right click */ $.fancybox.wrap.bind("contextmenu", function (e) { return false; }); } } }); function fnSubmittRegistrationPopup(){ var isValid = true; if($('#txtFirstName').val().trim() == "") { isValid = false; $('#txtFirstName').css('border-color', 'red'); } else if ($('#txtLastName').val().trim() == ""){ isValid = false; $('#txtLastName').css('border-color', 'red'); } else if ($('#txtEmail').val().trim() == ""){ isValid = false; $('#txtEmail').css('border-color', 'red'); } else if ($('#txtCompanyName').val().trim() == ""){ isValid = false; $('#txtCompanyName').css('border-color', 'red'); } else if ($('#ddlJobFunction').val().trim() == '0') { isValid = false; $('#lblJobFunctionRequired').show(); } else if ($("#ddlBusinessIndustry").val().trim() == '0') { isValid = false; $('#lblBusinessIndustryRequired').show(); } if ($('#txtEmail').val().trim() != "") { var EmailRex = /^(([^<>()[\]\\.,;:\s@"]+(\.[^<>()[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/; if (!EmailRex.test($('#txtEmail').val())) { isValid = false; $('#lbInvalidEmail').show(); } else { $('#lbInvalidEmail').hide(); } } if (isValid){ $.post( '/Article/RegistrationPopup', { firstName: $('#txtFirstName').val().trim(), lastName: $('#txtLastName').val().trim(), email: $('#txtEmail').val().trim(), companyName: $('#txtCompanyName').val().trim(), jobFunction: $('#ddlJobFunction').val().trim(), businessIndustry: $("#ddlBusinessIndustry").val().trim() }, function(response){ if (response){ $('#dvRegPopup').hide(); } } ); } } function fnCloseRegPopup(){ $.post('/Article/UpdatePopupCloseCount', function () { $('#dvRegPopup').hide(); }); } function fnAnswerReaderPoll() { if ($('input[name=rdoPollOptions]:checked').length > 0) { $('#btnPollAnser').attr("onclick", "").unbind("click"); $('#lblPollRequired').hide(); $.post('/Home/AnswerReaderPoll', { questionID: $('#hdnPollQuestionID').val(), optionID: $('input[name=rdoPollOptions]:checked').val(), answer: $('input[name=rdoPollOptions]:checked').attr('answer'), page: 'article', articleID : '912359848' }, function (response) { if (response.status) { debugger; //$('#PollQuestion').hide(); $('#PollOption').hide(); $('#btnPollAnser').hide(); //$('#lblPollSuccessMessage').show(); var html = "
      "; $.each(response.pollResult, function (index, obj) { html = html + "
    • " + obj.OptionText + " " + "
    • "; }); html = html + '
    '; $('#dvPollPercentage').append(html); $('#dvPollPercentage').show(); } }); } else{ $('#lblPollRequired').show(); } } function fnTrackLink(label, url, target) {debugger; $.post( '/Home/TrackButtonClicks', { linkName: label, guestUserID: getCookie("GuestUser"), url: url }, function () { if (target == "") { window.location.href = url; } else { //window.open(url); } }); }

    J&J, P&G sued after FDA panel ruling on decongestant - Business Insurance (1)

    Reprints

    J&J, P&G sued after FDA panel ruling on decongestant - Business Insurance (2)

    (Reuters)—A newlawsuitaccuses Johnson & Johnsonand Procter & Gamble of having deceived consumers about decongestant cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration advisory panel this week declared ineffective.

    According to a proposed class action filed Wednesday in federal court in Pensacola, Florida, the companies knew or should have known by 2018 that their marketing claims about products containing phenylephrine were false and misleading.

    That year was when new FDA guidance for evaluating symptoms related to nasal congestion demonstrated that earlier data about phenylephrine's effectiveness could no longer be relied upon, the complaint said.

    The plaintiff, Steve Audelo, said he bought Johnson & Johnson's Sudafed PE and Benadryl Allergy Plus Congestion, and Procter & Gamble's Vicks NyQuil, based on the companies' “false and deceptive” claims that the products worked.

    Mr. Audelo, a Florida resident, said the claims violated that state's consumer protection laws. He is seeking at least $5 million in damages for people who bought the products in the United States in the last five years.

    Benadryl and Sudafed are made by Johnson & Johnson's former consumer health care business, which was named as a defendant.

    The business was spun off in aMay 3 initial public offeringand is now known as Kenvue.

    Johnson & Johnson, Kenvue and Procter & Gamble did not immediately respond Thursday to requests for comment.

    The FDA panelreviewedseveral studies before concluding that phenylephrine was essentially no better than a placebo.

    According to an agency presentation, about 242 million products with phenylephrine were sold in the United States last year, generating $1.76 billion in sales and accounting for about four-fifths of the market for oral decongestants.

    Another decongestant, pseudoephedrine, is considered safe but has been moved behind pharmacy counters because people can process it illegally into methamphetamine. Sales of oral products that contain it totaled $542 million last year.

    Most Read in Risk Management

    • 1. Aon launches professional employer, staffing group

    • 2.

    • 3. Liberty Mutual reports $1.5 billion Q1 profit

    • 4. Highest-paid broker executives 2024

    • 5. Everest names regional retail leaders

    • 6. Berkshire reveals $6.72 billion Chubb stake, insurer's shares rise

    Sign up for Daily Briefing, the free email newsletter from Business Insurance.

  • J&J, P&G sued after FDA panel ruling on decongestant - Business Insurance (2024)

    References

    Top Articles
    Latest Posts
    Article information

    Author: Duane Harber

    Last Updated:

    Views: 5426

    Rating: 4 / 5 (51 voted)

    Reviews: 90% of readers found this page helpful

    Author information

    Name: Duane Harber

    Birthday: 1999-10-17

    Address: Apt. 404 9899 Magnolia Roads, Port Royceville, ID 78186

    Phone: +186911129794335

    Job: Human Hospitality Planner

    Hobby: Listening to music, Orienteering, Knapping, Dance, Mountain biking, Fishing, Pottery

    Introduction: My name is Duane Harber, I am a modern, clever, handsome, fair, agreeable, inexpensive, beautiful person who loves writing and wants to share my knowledge and understanding with you.